Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure

Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure

Abstract Background Uterine fibroids (UF) affect 77% of women by menopause, and account for $9.4 billion in annual healthcare costs. Type-2-diabetes (T2D) has inconsistently associated with protection from UFs in prior studies. To further evaluate the relationship between T2D and UFs we tested for a...

Full description

Bibliographic Details
Main Authors: Digna R. Velez Edwards, Katherine E. Hartmann, Melissa Wellons, Anushi Shah, Hua Xu, Todd L. Edwards
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Women's Health
Subjects:
Uterine leiomyoma
Epidemiology
Electronic medical records
Gynecologic
Type 2 diabetes
Online Access:http://link.springer.com/article/10.1186/s12905-017-0386-y

Internet

http://link.springer.com/article/10.1186/s12905-017-0386-y

Similar Items